Stock AVCN AVICANNA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Avicanna Inc.

Equities

AVCN

CA05368K1003

Biotechnology & Medical Research

Delayed Toronto S.E.
Other stock markets
 20:37:59 02/05/2024 BST 		5-day change 1st Jan Change
0.345 CAD -4.17% Intraday chart for Avicanna Inc. +1.47% -1.43%
04-19 Avicanna Raises About $2.1 Million in Non-brokered Private Placement MT
04-18 Avicanna Inc. announced that it has received CAD 2.125584 million in funding CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 56.63 49.1 35.79 30.73 31.74
Enterprise Value (EV) 1 60.78 48.53 37.42 32.75 33.06
P/E ratio -2.42 x -1.17 x -1.92 x -1.65 x -3.39 x
Yield - - - - -
Capitalization / Revenue 337 x 31.3 x 10.9 x 7.59 x 1.89 x
EV / Revenue 361 x 30.9 x 11.4 x 8.09 x 1.97 x
EV / EBITDA -2.71 x -2.77 x -3.45 x -3.34 x -4.2 x
EV / FCF -3.72 x -6.9 x -4 x -4.97 x -8.46 x
FCF Yield -26.9% -14.5% -25% -20.1% -11.8%
Price to Book 2.54 x 7.81 x 31.2 x -80.1 x -282 x
Nbr of stocks (in thousands) 22,295 37,485 45,884 74,953 90,677
Reference price 2 2.540 1.310 0.7800 0.4100 0.3500
Announcement Date 15/04/20 03/09/21 31/03/22 31/03/23 02/04/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.118 0.1683 1.57 3.269 4.048 16.79
EBITDA 1 -8.273 -22.43 -17.49 -10.85 -9.812 -7.871
EBIT 1 -8.446 -23.22 -18.27 -11.41 -10.41 -8.38
Operating Margin -7,159.47% -13,802.86% -1,163.96% -349.15% -257.18% -49.9%
Earnings before Tax (EBT) 1 -7.289 -23.25 -35.05 -16.76 -14.74 -8.743
Net income 1 -7.099 -21.07 -32.86 -16.77 -14.74 -8.743
Net margin -6,017.63% -12,524.06% -2,093.02% -513.15% -364.02% -52.07%
EPS 2 -0.5225 -1.051 -1.118 -0.4063 -0.2490 -0.1032
Free Cash Flow 1 -7.411 -16.36 -7.034 -9.344 -6.588 -3.908
FCF margin -6,282.09% -9,720.86% -448% -285.86% -162.76% -23.28%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 12/06/19 15/04/20 03/09/21 31/03/22 31/03/23 02/04/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1
Net sales 1 0.988 1.218 1.038
EBITDA 1 -2.256 -2.059 -0.3982
EBIT 1 -2.466 -2.288 -0.6517
Operating Margin -249.63% -187.87% -62.79%
Earnings before Tax (EBT) 1 -2.671 -8.218 -0.9391
Net income 1 -2.671 -8.231 -0.9391
Net margin -270.34% -675.92% -90.47%
EPS 2 -0.0700 -0.1800 -0.0204
Dividend per Share - - -
Announcement Date 12/11/21 31/03/22 12/05/22
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.28 4.15 - 1.63 2.02 1.33
Net Cash position 1 - - 0.58 - - -
Leverage (Debt/EBITDA) -0.0334 x -0.1849 x - -0.1503 x -0.2054 x -0.1685 x
Free Cash Flow 1 -7.41 -16.4 -7.03 -9.34 -6.59 -3.91
ROE (net income / shareholders' equity) -53.6% -79% -150% -161% -284% -153%
ROA (Net income/ Total Assets) -34.8% -37.9% -30.3% -27.2% -32.6% -26.5%
Assets 1 20.37 55.57 108.4 61.68 45.2 33.05
Book Value Per Share 2 1.170 1.000 0.1700 0.0200 -0.0100 -0
Cash Flow per Share 2 0 0.0200 0.0400 0 0.0200 0.0100
Capex 1 3.87 6.79 1.39 0.77 0.05 0.04
Capex / Sales 3,278.52% 4,038.09% 88.35% 23.53% 1.25% 0.27%
Announcement Date 12/06/19 15/04/20 03/09/21 31/03/22 31/03/23 02/04/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
AVICANNA INC. Stock Avicanna Inc.
-1.43% 25.54M
MODERNA, INC. Stock Moderna, Inc.
+26.84% 42.68B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-3.76% 42.4B
LONZA GROUP AG Stock Lonza Group AG
+45.32% 40.04B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.68% 24.94B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.45% 18.96B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.88% 12.3B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.76% 11.95B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-1.83% 11.55B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. AVCN Stock
  4. Financials Avicanna Inc.